<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04074720</url>
  </required_header>
  <id_info>
    <org_study_id>16D.674</org_study_id>
    <nct_id>NCT04074720</nct_id>
  </id_info>
  <brief_title>Prospective Breast Cancer Biospecimen Collection</brief_title>
  <official_title>Prospective Breast Cancer Biospecimen Collection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thomas Jefferson University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Thomas Jefferson University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tissue will be procured during a standard of care procedure the patient will already be
      scheduled to undergo. A one time blood draw will be performed at this time and an optional
      rectal swab for biome analysis may occur. Follow Up will only consist of chart review to
      determine date of recurrence, metastases, and/or death
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 10, 2018</start_date>
  <completion_date type="Anticipated">January 22, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 22, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tumor biomarker identification</measure>
    <time_frame>Up to 5 years</time_frame>
    <description>Collected biospecimens will be analyzed using current laboratory techniques to identify the presence of breast cancer biomarkers such as estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Laboratory-based breast cancer tumor genomic profile</measure>
    <time_frame>Up to 5 years</time_frame>
    <description>Genomic profile will be based on laboratory analysis of the collected tumor tissue biospecimens to identify how genes interact with the tumor and its environment.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Invasive Breast Cancer</condition>
  <condition>Carcinoma in Situ of the Breast</condition>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patients will have tissue procured after a standard of care procedure, a one time blood draw performed, and optional rectal swab</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tissue Sample collection</intervention_name>
    <description>Tissue sample collected following standard of care procedure patient was already scheduled to have</description>
    <arm_group_label>Standard of Care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood Sample Collection</intervention_name>
    <description>A one time sample of blood will be collected on day of standard of care procedure</description>
    <arm_group_label>Standard of Care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Rectal Swab</intervention_name>
    <description>optional rectal swab may be collected on day of standard of care procedure</description>
    <arm_group_label>Standard of Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults &gt;18 years old at time of consent

          -  Subject must be capable to giving informed consent or have an acceptable surrogate
             capable of giving consent on the subject behalf.

          -  Patients with carcinoma in situ or invasive breast cancer

          -  Patient must be undergoing one of the following:

               -  definitive surgical tumor resection for breast cancer OR

               -  placement of a vascular access device as a prelude to neoadjuvant therapy for
                  breast cancer OR

               -  neurosurgical resection of a brain metastasis from primary breast cancer.

        Exclusion Criteria:

          -  &lt;18 years old

          -  Not able to give informed consent and does not have acceptable surrogate capable to
             giving informed consent.

          -  Active drug/alcohol dependence or abuse history
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicole Simone, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sidney Kimmel Cancer Center at Thomas Jefferson University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nicole Simone, MD</last_name>
    <phone>215-955-6702</phone>
    <email>Nicole.Simone@jefferson.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sidney Kimmel Cancer Center at Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Simone</last_name>
      <phone>215-955-6702</phone>
      <email>Nicole.Simone@jefferson.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 1, 2019</study_first_submitted>
  <study_first_submitted_qc>August 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 30, 2019</study_first_posted>
  <last_update_submitted>August 27, 2019</last_update_submitted>
  <last_update_submitted_qc>August 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Carcinoma in Situ</mesh_term>
    <mesh_term>Breast Carcinoma In Situ</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

